• About us
• Contact

Advertisement

Organisation › Details

BioFocus DPI (divsion of Galapagos)

As the service business unit for Galapagos NV, an integrated drug discovery company, BioFocus DPI aims to expand our partners’ drug pipelines by accelerating the gene-to-candidate discovery process. We achieve this by offering a biologically-focused discovery platform with three key differentiators: • target discovery in human primary cells • hit discovery using focused chemogenomic libraries as well as diverse compound collections • predictive drug discovery tools. Through a proprietary adenoviral platform with human full-length cDNA and shRNA constructs, we are able to rapidly identify and validate disease-modifying drug targets. Once a target has been selected, our focused small-molecule libraries, large diversity collection and natural product libraries can be applied to generate hits. These hits can then be further optimized through our predictive drug discovery tools applied in medicinal and computational chemistry as well as through our assay development, high throughput screening, and ADME optimization - thereby progressing our partners’ discovery programs. BioFocus DPI has over 300 employees and operates facilities across Europe and the US. *

 

	Start	2006-06-13 renamed
	Group	Charles River (Group)
	Predecessor	BioFocus (divsion of Galapagos)
	Industry	drug discovery technology
	Industry 2	drug discovery services
	City	CB10 1XL Little Chesterford, Essex
	Tel	+44-1799-533-500
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Charles River (Group)

• [1] Charles River Laboratories International, Inc.. (1/30/23). "Press Release: Charles River Laboratories Acquires SAMDI Tech". Wilmington, MA....
• [2] Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA....
• [3] Charles River Laboratories International, Inc.. (1/4/21). "Press Release: Charles River Laboratories Acquires Distributed Bio". Wilmington, MA....
• [4] Charles River Laboratories International, Inc.. (4/29/19). "Press Release: Charles River Laboratories Completes the Acquisition of Citoxlab". Wilmington, MA....
• [5] Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA....
• [6] Cobra Biologics Ltd.. (11/26/18). "Press Release: Cobra Biologics, Pall Corporation and the Cell and Gene Therapy Catapult Win £1.5M Innovate UK Grant to Investigate Continuous Manufacturing for Gene Therapies". Keele & Port Washington, NY & London....
• [7] Charles River Laboratories International, Inc.. (5/1/18). "Press Release: Charles River Laboratories Expands Services for Early Discovery Screening". Wilmington, DE....
• [8] Charles River Laboratories International, Inc.. (3/8/18). "Press Release: Charles River Laboratories Makes Expansions to Global Biologics Infrastructure". Wilmington, MA....
• [9] Charles River Laboratories International, Inc.. (11/28/17). "Press Release: Charles River Announces Success of Integrated Discovery Project with Enyo Pharma". Wilmington, MA & Lyon....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.